Genetic alterations of the WT1 gene in papillary serous carcinoma of the peritoneum

Gynecologic Oncology

Volumn 76, Issue 3, 2000, Pages 369-372

  Schorge, John O ^a   Miller, Yvette B ^a   Qi, Lai Jun ^a   Muto, Michael G ^a   Welch, William R ^a   Berkowitz, Ross S ^a   Mok, Samuel C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Loss of heterozygosity; Ovarian neoplasms; Peritoneal neoplasms; WT1

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; HETEROZYGOSITY LOSS; HUMAN; OVARY CARCINOMA; PERITONEUM CANCER; PREDICTION; PRIORITY JOURNAL;

EID: 0034012540     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1999.5711     Document Type: Article

References (20)

1. Pritchard-Jones K, Fleming S, Davidson D, Bickmore W, Porteous D, Gosden C, Bard J, Buckler A, Pelletier J, Housman D. The candidate Wilms' tumour gene is involved in genitourinary development. Nature. 346:1990;194-197.
2. Pelletier J, Schalling M, Buckler A, Rogers A, Haber D, Housman D. Expression of the Wilms' tumor gene WT1 in the murine urogenital system. Genes Dev. 5:1991;1345-1356.
3. Bruening W, Gros P, Sato T, Stanimir J, Nakamura Y, Housman D, Pelletier J. Analysis of the 11p13 Wilms' tumor suppressor gene (WT1) in ovarian tumors. Cancer Invest. 11:1993;393-399.
4. Viel A, Giannini F, Capozzi E, Canzonieri V, Scarabelli C, Gloghini A, Boiocchi M. Molecular mechanisms possibly affecting WT1 function in human ovarian tumors. Int J Cancer. 57:1994;515-521.
5. Vandamme B, Lissens W, Amfo K, De Sutter P, Bourgain C, Vamos E, De Greve J. Deletion of chromosome 11p13-11p15.5 sequences in invasive human ovarian cancer is a subclonal progression factor. Cancer Res. 52:1992;6646-6652.
6. Viel A, Giannini F, Tumiotto L, Sopracordevole F, Visentin M C, Boiocchi M. Chromosomal localisation of two putative 11p oncosuppressor genes involved in human ovarian tumours. Brit J Cancer. 66:1992;1030-1036.
7. Piver M S, Jishi M F, Tsukada Y, Nava G. Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. A report of the Gilda Radner Familial Ovarian Cancer Registry. Cancer. 71:1993;2751-2755.
8. Tobacman J K, Greene M H, Tucker M A, Costa J, Kase R, Fraumeni J F. Intra-abdominal carcinomatosis after prophylactic oophorectomy in ovarian-cancer-prone families. Lancet. 2:1982;795-797.
9. Muto M G, Welch W R, Mok S C, Bandera C A, Fishbaugh P M, Tsao S W, Lau C C, Goodman H M, Knapp R C, Berkowitz R S. Evidence for a multifocal origin of papillary serous carcinoma of the peritoneum. Cancer Res. 55:1995;490-492.
10. Schorge J O, Muto M G, Welch W R, Bandera C A, Rubin S C, Bell D A, Berkowitz R S, Mok S C. Molecular evidence for multifocal papillary serous carcinoma of the peritoneum in patients with germline BRCA1 mutations. J Natl Cancer Inst. 90:1998;841-845.
11. International Federation of Gynecology and Obstetrics, Annual report on the results of treatment in gynecological cancer, vol, 21, FIGO, Stockholm, 1991, pp, 238, - 239.
12. Bloss J D, Liao S Y, Buller R E, Manetta A, Berman M L, McMeekin S, Bloss L P, DiSaia P J. Extraovarian peritoneal serous papillary carcinoma: A case-control retrospective comparison to papillary adenocarcinoma of the ovary. Gynecol Oncol. 50:1993;347-351.
13. Mok S C, Bell D A, Knapp R C, Fishbaugh P M, Welch W R, Muto M G, Berkowitz R S, Tsao S W. Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy. Cancer Res. 53:1993;1489-1492.
14. Schorge, J, O, Muto, M, G, Lee, S, J, Huang, L, W, Welch, W, R, Bell, D, A, Keung, E, ZY, Berkowitz, R, S, Mok, S, C, BRCA1-related papillary serous carcinoma of the peritoneum has a unique molecular pathogenesis, Cancer Res, in press.
15. Chan, W, Y, Cheung, K, K, Schorge, J, O, Huang, L, W, Welch, W, R, Bell, D, A, Berkowitz, R, S, Mok, S, C, Relationship of bcl-2 and p53 protein expression, apoptosis and p53 mutation in human epithelial ovarian tumors, Am J Pathol, in press.
16. Fraizer G C, Wu Y J, Hewitt S M, Maity T, Ton C CT, Huff V, Sanders G F. Transcriptional regulation of the human Wilms' tumor gene (WT1). J Biol Chem. 269:1994;8892-8900.
17. Malik K TA, Wallace J I, Ivins S M, Brown K W. Identification of an antisense WT1 promoter in intron 1: Implications for WT1 gene regulation. Oncogene. 11:1995;1589-1595.
18. Debhi M, Hiscott, Pelletier J. Activation of the wt1 Wilm's tumor suppressor gene by NF-kappaB. Oncogene. 16:1998;2033-2039.
19. Maheswaran S, Park S, Bernard A, Morris J F, Rauscher F J 3d, Hill D E, Haber D A. Physical and functional interaction between WT1 and p53 proteins. Proc Natl Acad Sci USA. 90:1993;5100-5104.
20. Maheswaran S, Englert C, Bennett P, Heinrich G, Haber D A. The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis. Genes Dev. 9:1995;2143-2156.